invention may comprise one or more stabilizers such as but not limited to for example carbohydrates including sorbitol mannitol starch sucrose dextrin and glucose proteins such as albumin or casein and buffers like alkaline phosphates furthermore the composition of the present invention may comprise one or more adjuvants that enhance the hypotensive properties of the peptides of the invention the specific novel peptides derived from yellow pea were identified to inhibit or reduce renin activity the invention also encompasses therapeutic strategies that involve administering one or more of the novel peptides of the invention to a subject in need these methods may be used in combination with other known therapies for treating conditions and diseases related to high blood pressure or disturbances of cardiac function such as hypertension cardio vascular disease and chronic kidney disease the term u201c subject u201d as used in this document includes all members of the animal kingdom including mammals preferably humans the invention also encompasses therapeutic strategies that involve targeting the ras pathway to down regulate blood pressure in a subject these methods may be used in combination with other known therapies for reducing blood pressure in a subject in humans high blood pressure is involved in many diseases such as cardiovascular disease and chronic kidney disease as such the instant invention also encompasses methods for the treatment of cardiovascular disease and chronic kidney disease in a subject comprising the administration to the subject of a therapeutic composition comprising one or more of the peptides of the invention the peptides of the invention may be labeled with a label to facilitate their detection in a variety of assays as is understood by one of skill in the art such labels may include but are not limited to radioactive label and fluourescent label the peptides.